VIB Inks qBase+ Group Licensing Agreement with Biogazelle
News May 20, 2013
BITS, the bio-informatics training and service facility of the Belgian life sciences research institute VIB, has chosen qbase+ as the software to accelerate its qPCR analyses.
The qbase+ group license is available for more than ten VIB departments covering over 1000 researchers.
The director of BITS, Herwig Van Marck, cited: “qbase+ will allow us to improve the accuracy of our results and bring our qPCR based research to a higher level. The peer-reviewed software algorithms will help our researcher to annotate and process qPCR data according to international guidelines. To ensure the quality of the data we can rely on the various calculations available in qbase+ for post-PCR quality control, PCR efficiency correction, normalization, inter-run calibration, and statistics. This way, VIB researchers can efficiently analyze, interpret and visualize their data for various types of analysis: mRNA expression analysis, copy number analysis, miRNA profiling, ChIP-qPCR, and many others.”
While the practical performance of a real-time PCR quantification experiment is relatively straightforward, it is clear that many users experience a genuine need for more in depth training of their data-analysis skills.
To accommodate this need, Biogazelle has organized several training sessions for key qPCR users within VIB.
Within the framework of the collaboration, VIB can also rely on expert advice from Biogazelle.
scNMT-seq Allows Analysis of Connections Between Nucleosomes, Methylation and TranscriptionNews
A new bioinformatics technique allows researchers to study three key processes inside the cell simultaneously.READ MORE
I See What You're Thinking: Successful Image Reconstruction Using EEGNews
In a world first, scientists have been able to recreate images perceived by test subjects using only data from their EEG scans.READ MORE
CRISPR Study Reveals Errors in Earlier Cancer ResearchNews
MELK, a protein previously thought to be implicated in cancer, has been shown to be unrelated to the disease.READ MORE